Insider Transactions in Q3 2023 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
6,166
-78.92%
|
$172,648
$28.05 P/Share
|
|
Sep 05
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
4,519
+36.64%
|
$27,114
$6.8 P/Share
|
|
Aug 09
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
1,718
-34.28%
|
$41,232
$24.66 P/Share
|
|
Aug 09
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
1,718
+25.53%
|
$10,308
$6.8 P/Share
|
|
Aug 07
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
11,223
-77.31%
|
$269,352
$24.18 P/Share
|
|
Aug 07
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
8,591
+37.18%
|
$51,546
$6.8 P/Share
|
|
Jul 26
2023
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
930
-9.95%
|
$15,810
$17.64 P/Share
|
|
Jul 26
2023
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+25.05%
|
-
|